| # | Drug | Count |
|---|---|---|
| 0 | PACLITAXEL | 9 |
| 1 | PACLITAXEL (AIBUMIN-BOUND) | 9 |
| 2 | BICALUTAMIDE | 8 |
| 3 | TRASTUZUMAB | 7 |
| 4 | CARBOPLATIN | 6 |
| 5 | DENOSUMAB | 5 |
| 6 | LEUPROLIDE ACETATE | 5 |
| 7 | CYCLOPHOSPHAMIDE | 4 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 4 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIPTORELIN | 4 | 0.0012 |
| 1 | LAROTRECTINIB | 1 | 0.0011 |
| 2 | FLUTAMIDE | 1 | 0.0010 |
| 3 | BICALUTAMIDE | 8 | 0.0005 |
| 4 | ONASEMNOGENE ABEPARVOVEC-XIOI | 1 | 0.0004 |
| 5 | DABRAFENIB | 4 | 0.0002 |
| 6 | TRAMETINIB | 4 | 0.0002 |
| 7 | IMMUNE GLOBULIN INTRAVENOUS (HUMAN) | 1 | 0.0002 |
| 8 | VINORELBINE | 1 | 0.0001 |
| 9 | LAPATINIB | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adenosine Receptor Agonist [EPC] | 1 | 0.0001 |
| 1 | Androgen Receptor Inhibitor [EPC] | 8 | 0.0001 |
| 2 | HER2/neu Receptor Antagonist [EPC] | 7 | 0.0001 |
| 3 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 4 | Microtubule Inhibitor [EPC] | 11 | 0.0001 |
| 5 | Nitrofuran Antibacterial [EPC] | 1 | 0.0001 |
| 6 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 9 | Platinum-based Drug [EPC] | 8 | 0.0000 |